Complete Dose Comparison: Your Treatment Journey Mapped
Mounjaro vs Wegovy Dose Equivalent: Understanding the Fundamental Differences
When comparing Mounjaro vs Wegovy dose equivalents, it's essential to understand these are entirely different medications with distinct mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro uses tirzepatide, which targets both GIP and GLP-1 receptors as a dual agonist. This means direct dose equivalency isn't possible - each medication follows its own clinically-tested escalation schedule designed for optimal tolerability and efficacy.
Wegovy's five-dose progression spans 17 weeks: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. Mounjaro follows a different pattern with six doses over 20 weeks, reaching a maximum of 15mg weekly. The key consideration isn't finding equivalent doses between treatments, but ensuring your chosen pharmacy stocks every dose for seamless progression - which EverydayMeds ensures for Wegovy patients.
Complete Wegovy Pricing Structure: Every Dose Available Now
Our comprehensive Wegovy pricing ensures transparent costs throughout your treatment journey. Single pens start at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25 - these codes are essential to access our competitive pricing structure.
Bundle options provide convenience for continuous treatment: our Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first 12 weeks, whilst the Progress Trio (0.5mg, 1mg, 1.7mg) at £369.99 suits patients extending their dose escalation. For maintenance patients, our Ultimate Stability Trio provides three months of 2.4mg supply for £649.99. All bundles include next-day cold-chain delivery and eliminate the need for multiple orders during critical treatment phases.
Clinical Evidence Supporting Wegovy's Dosing Strategy
The STEP clinical trial programme, published by Wilding et al. in the New England Journal of Medicine (2021), established Wegovy's evidence base across multiple populations. STEP 1 demonstrated that patients taking Wegovy 2.4mg alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo.
The graduated dosing approach proven in these trials minimises gastrointestinal side effects whilst optimising therapeutic outcomes. STEP 5 data showed sustained weight loss of approximately 15.2% at two years, reinforcing the importance of consistent dose progression and maintenance therapy - precisely why having access to every Wegovy dose matters for long-term success.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and glucose metabolism. When injected weekly, semaglutide binds to GLP-1 receptors in the brain's appetite centres, reducing hunger signals and promoting satiety after smaller meals. The medication slows gastric emptying, meaning food remains in your stomach longer, contributing to prolonged fullness. Additionally, Wegovy may help reduce food cravings and the psychological drive to eat, particularly for high-calorie foods. This multi-faceted approach explains why the dose escalation protocol is crucial - higher doses provide more sustained appetite control, but must be reached gradually to maintain tolerability throughout your treatment journey.
Streamlined Ordering Process for All Wegovy Doses
Accessing any Wegovy dose through EverydayMeds begins with our 3-minute online clinical assessment, covering your medical history, current medications, and weight management goals. Our registered prescribers review your application within 3 working days (express 24-hour service available), ensuring clinical appropriateness for your chosen dose. Once approved, your medication ships via next-day cold-chain delivery, maintaining the 2-8°C temperature requirement throughout transit. Our process accommodates dose progression seamlessly - simply reorder your next dose when ready, with your clinical profile already established. This eliminates the common frustration of changing pharmacies due to stock shortages, ensuring uninterrupted treatment from starter to maintenance doses.
Storage Advantages and Practical Considerations
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable for 6 weeks at room temperature below 30°C once removed from the fridge, versus Mounjaro's 21-day limit. This advantage matters significantly for frequent travellers or those with unpredictable schedules. The FlexTouch pen design provides intuitive dose delivery with audible clicks confirming correct dosing, whilst the dose counter shows remaining medication clearly. Each pen delivers exactly 4 doses at the prescribed strength, with dose escalation mandatory - you cannot skip doses or accelerate the schedule safely. Store unopened pens in the fridge at 2-8°C, and never freeze or shake the medication, as this affects its molecular structure and therapeutic efficacy.
Why Complete Dose Availability Matters for Mounjaro vs Wegovy Decisions
Many patients initially comparing Mounjaro vs Wegovy dose equivalents overlook a critical factor: pharmacy stock reliability throughout their treatment journey. Weight management medications require consistent dosing over months or years - interruptions can compromise therapeutic outcomes and necessitate dose re-escalation. EverydayMeds maintains comprehensive Wegovy inventory from 0.25mg through 2.4mg, plus our new 7.2mg dose when available.
This complete range means you'll never face treatment interruptions due to supply issues, a common problem with pharmacies stocking limited dose ranges. Our bundle options further reliable supply continuity, whilst our clinical team understands the complete Wegovy dosing journey. When comparing treatment options, consider not just the initial prescription, but your entire treatment pathway - EverydayMeds supports Wegovy patients from first injection through long-term maintenance.
Start Your Wegovy Journey: Complete Dose Support Available
Whether you're comparing Mounjaro vs Wegovy dose options or ready to begin treatment, EverydayMeds provides comprehensive support throughout your weight management journey. Apply code FIRST40 (new customers) or DOSE25 (returning patients) at checkout to access our competitive pricing structure. Our complete dose range eliminates the common problem of changing pharmacies mid-treatment, whilst our clinical team understands the nuances of Wegovy's escalation protocol. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and secure your complete dose pathway. Remember, Wegovy is a prescription-only medicine requiring clinical assessment and should be used alongside a reduced-calorie diet and increased physical activity. Your long-term success depends on consistent dosing - let EverydayMeds be your partner throughout the entire journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
